|
|
| Phases of Development | Preclinical | Phase I | Phase I/II | Phase II | Phase III | Registration | Approved | Marketed |
|---|
| Dermatology | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | | Endocrine / Metabolic | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | | Gastrointestinal | 1 | 1 | 0 | 1 | 4 | 0 | 0 | 2 | | Genitourinary | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | Neurology | 2 | 12 | 1 | 10 | 6 | 4 | 2 | 28 |
|
|
Products Targeting Mu opioid receptor (OPRM1) (MOR)